Literature DB >> 32657585

Structural Basis of Noscapine Activation for Tubulin Binding.

María A Oliva1, Andrea E Prota2, Javier Rodríguez-Salarichs1, Youssef L Bennani3, Jesús Jiménez-Barbero4,5,6, Katja Bargsten2, Ángeles Canales7, Michel O Steinmetz2,8, J Fernando Díaz1.   

Abstract

Noscapine is a natural alkaloid that is used as an antitussive medicine. However, it also acts as a weak anticancer agent in certain in vivo models through a mechanism that is largely unknown. Here, we performed structural studies and show that the cytotoxic agent 7A-O-demethoxy-amino-noscapine (7A-aminonoscapine) binds to the colchicine site of tubulin. We suggest that the 7A-methoxy group of noscapine prevents binding to tubulin due to a steric clash of the compound with the T5-loop of α-tubulin. We further propose that the anticancer activity of noscapine arises from a bioactive metabolite that binds to the colchicine site of tubulin to induce mitotic arrest through a microtubule cytoskeleton-based mechanism.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32657585     DOI: 10.1021/acs.jmedchem.0c00855

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

Review 1.  Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.

Authors:  Jiaxing Wang; Duane D Miller; Wei Li
Journal:  Drug Discov Today       Date:  2021-12-08       Impact factor: 7.851

2.  Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.

Authors:  Susan Matthew; Qi-Yin Chen; Ranjala Ratnayake; Charles S Fermaintt; Daniel Lucena-Agell; Francesca Bonato; Andrea E Prota; Seok Ting Lim; Xiaomeng Wang; J Fernando Díaz; April L Risinger; Valerie J Paul; Maria Ángela Oliva; Hendrik Luesch
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

3.  Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function.

Authors:  María Ángela Oliva; Carlota Tosat-Bitrián; Lucía Barrado-Gil; Francesca Bonato; Inmaculada Galindo; Urtzi Garaigorta; Beatriz Álvarez-Bernad; Rebeca París-Ogáyar; Daniel Lucena-Agell; Juan Francisco Giménez-Abián; Isabel García-Dorival; Jesús Urquiza; Pablo Gastaminza; José Fernando Díaz; Valle Palomo; Covadonga Alonso
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.